tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Artivion Inc

AORT
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
25.080USD
+0.430+1.74%
์ข…๊ฐ€ย 09-11 16:00๏ผˆET๏ผ‰
1.22B์‹œ๊ฐ€์ด์•ก
97.70P/E TTM
์žฅ์™ธ ๊ฑฐ๋ž˜ย 19:00ย (ET)25.080USD-0.020-0.08%

์ž์„ธํ•œ ๋‚ด์šฉ์€ Artivion Inc ํšŒ์‚ฌ

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeonsโ€™ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc ํ”„๋กœํ•„

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ AORT
ํšŒ์‚ฌ ์ด๋ฆ„Artivion Inc
์ƒ์žฅ์ผFeb 12, 1993
CEOMackin (James Patrick)
์ง์› ์ˆ˜1600
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒFeb 12
์ฃผ์†Œ1655 Roberts Boulevard N W
๋„์‹œKENNESAW
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ30144
์ „ํ™”17704193355
์›น์‚ฌ์ดํŠธhttps://artivion.com/
์ข…๋ชฉ ์ฝ”๋“œ AORT
์ƒ์žฅ์ผFeb 12, 1993
CEOMackin (James Patrick)

Artivion Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. John E. Davis
Mr. John E. Davis
Chief Commercial Officer
Chief Commercial Officer
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer
166.83K
-0.43%

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Artivion Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Artivion Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค: Mr. John E. Davis

Artivion Inc(AORT)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2026Q1 ๊ธฐ์ค€์œผ๋กœ, Artivion Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 449๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 45.29M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 93.40%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q4 ๋Œ€๋น„ 501666.00 ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

Artivion Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
2026Q1 ๊ธฐ์ค€, Artivion Inc์˜ Aortic stent grafts ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ 46.41M๋กœ ์ „์ฒด ๋งค์ถœ์˜ 36.91%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ